A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusion
Authors:
Open Access
- 15 March 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 44 (6) , 824-826
Abstract
Sir, A 60-yr-old Japanese female visited our hospital in August of 2000 complaining of Raynaud's phenomenon. On physical examination, skin sclerosis was evident on the fingers, hands, forearms, upper arms, face, chest, abdomen, lower legs and the dorsum of the feet. The modified Rodnan total skin thickness score (TSS) [1] was 24. Nailfold bleeding and flexion contractions of the phalanges were also observed. She had no symptoms suggestive of other collagen diseases.Keywords
This publication has 7 references indexed in Scilit:
- Impaired Smad7-Smurf–mediated negative regulation of TGF-β signaling in scleroderma fibroblastsJournal of Clinical Investigation, 2004
- Blockade of endogenous transforming growth factor β signaling prevents up‐regulated collagen synthesis in scleroderma fibroblasts: Association with increased expression of transforming growth factor β receptorsArthritis & Rheumatism, 2001
- Skin Score Decrease in Systemic Sclerosis Patients Treated with Intravenous Immunoglobulin - A Preliminary ReportClinical Rheumatology, 2000
- Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritisThe Lancet, 1999
- Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma PhenotypeJournal of Investigative Dermatology, 1998
- Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseasesJournal of Allergy and Clinical Immunology, 1997
- Intravenous immunoglobulin for polymyositis and dermatomyositisThe Lancet, 1990